These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Neuroprotective effects of MK-801, TCP, PCP and CPP against N-methyl-D-aspartate induced neurotoxicity in an in vivo perinatal rat model. McDonald JW; Silverstein FS; Johnston MV Brain Res; 1989 Jun; 490(1):33-40. PubMed ID: 2667694 [TBL] [Abstract][Full Text] [Related]
23. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. Foster AC; Wong EH Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170 [TBL] [Abstract][Full Text] [Related]
24. Competitive and noncompetitive N-methyl-D-aspartate antagonists modify hypoxia-induced membrane potential changes and protect rat hippocampal slices from functional failure: a quantitative comparison. Grigg JJ; Anderson EG J Pharmacol Exp Ther; 1990 Apr; 253(1):130-5. PubMed ID: 1970359 [TBL] [Abstract][Full Text] [Related]
26. The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: a voltage clamp study on neuronal cells in culture. Halliwell RF; Peters JA; Lambert JJ Br J Pharmacol; 1989 Feb; 96(2):480-94. PubMed ID: 2647206 [TBL] [Abstract][Full Text] [Related]
27. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures. Gilbert ME Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609 [TBL] [Abstract][Full Text] [Related]
28. NMDA receptor antagonists inhibit kindling epileptogenesis and seizure expression in developing rats. Trommer BL; Pasternak JF Brain Res Dev Brain Res; 1990 May; 53(2):248-52. PubMed ID: 2162746 [TBL] [Abstract][Full Text] [Related]
29. The neuroprotective action of ketamine and MK-801 after transient cerebral ischemia in rats. Church J; Zeman S; Lodge D Anesthesiology; 1988 Nov; 69(5):702-9. PubMed ID: 2847595 [TBL] [Abstract][Full Text] [Related]
30. The N-methyl-D-aspartate antagonists aminophosphonovaleric acid and MK-801 reduce anoxic damage to dentate granule and CA1 pyramidal cells in the rat hippocampal slice. Kass IS; Chambers G; Cottrell JE Exp Neurol; 1989 Feb; 103(2):116-22. PubMed ID: 2563246 [TBL] [Abstract][Full Text] [Related]
31. Quantitative autoradiography of [3H]-MK-801 binding sites in mammalian brain. Bowery NG; Wong EH; Hudson AL Br J Pharmacol; 1988 Apr; 93(4):944-54. PubMed ID: 3291999 [TBL] [Abstract][Full Text] [Related]
32. MK-801 prevents cognitive and behavioral deficits produced by NMDA receptor overstimulation in the rat hippocampus. Rogers BC; Tilson HA Toxicol Appl Pharmacol; 1989 Jul; 99(3):445-53. PubMed ID: 2546291 [TBL] [Abstract][Full Text] [Related]
34. The effects of non-competitive NMDA receptor antagonists on rats exposed to hyperbaric pressure. Wardley-Smith B; Wann KT Eur J Pharmacol; 1989 Jun; 165(1):107-12. PubMed ID: 2548878 [TBL] [Abstract][Full Text] [Related]
35. Differences in results from in vivo and in vitro studies on the use-dependency of N-methylaspartate antagonism by MK-801 and other phencyclidine receptor ligands. Davies SN; Martin D; Millar JD; Aram JA; Church J; Lodge D Eur J Pharmacol; 1988 Jan; 145(2):141-51. PubMed ID: 2832187 [TBL] [Abstract][Full Text] [Related]
36. [3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. Wong EH; Knight AR; Woodruff GN J Neurochem; 1988 Jan; 50(1):274-81. PubMed ID: 2826686 [TBL] [Abstract][Full Text] [Related]
38. Effects of the NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat. Young NA; Lewis SJ; Vajda FJ; Beart PM Exp Neurol; 1989 Feb; 103(2):199-202. PubMed ID: 2536332 [TBL] [Abstract][Full Text] [Related]
39. N-methyl-D-aspartate receptor binding is altered and seizure potential reduced in pregnant rats. Standley CA Brain Res; 1999 Oct; 844(1-2):10-9. PubMed ID: 10536256 [TBL] [Abstract][Full Text] [Related]
40. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline. Willetts J; Balster RL J Pharmacol Exp Ther; 1989 Nov; 251(2):627-33. PubMed ID: 2553930 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]